← SynDRA
QUINELORANE
SynDRA canonical compound SYN0005174 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | DRD2 | DRD3 |
| Mechanism of action | dopamine receptor agonist |
All known targets
Mechanisms of action (all sources)
- dopamine receptor agonist
- DRD3 MODULATOR
Drug classes
Cross-references
Synonyms
- Quinelorano
- Quinelorane [INN:BAN]
- Quineloranum [INN-Latin]
- UNII-Z0X4VT3Y1Q
- Quinelorano [INN-Spanish]
- Z0X4VT3Y1Q
- LY 163502
- LY 137157
- LY 175877
- CHEMBL155731
- (5aR,9aR)-6-propyl-5a,7,8,9,9a,10-hexahydro-5H-pyrido[2,3-g]quinazolin-2-amine
- (5aR-trans)-5,5a,6,7,8,9,9a,10-Octahydro-6-propylpyrido(2,3-g)quinazolin-2-amine
- Pyrido(2,3-g)quinazolin-2-amine, 5,5a,6,7,8,9,9a,10-octahydro-6-propyl-, (5aR-trans)-
- DSSTox_RID_81533
- DSSTox_CID_26315
- DSSTox_GSID_46315
- Quineloranum
- CAS-97466-90-5
- LY-16350
- DTXCID2026315
- RefChem:930470
- Quinerolane
- NCGC00162319-02
- Lopac-Q-110
- QUINELORANE [INN]
- Biomol-NT_000026
- Lopac0_001020
- GTPL954
- SCHEMBL378583
- BPBio1_001213
- orb1695553
- SCHEMBL29710902
- CHEBI:92230
- Tox21_112009
- BDBM50016017
- PDSP2_000522
- AKOS040753676
- Tox21_112009_1
Look up QUINELORANE in the interactive SynDRA portal →